Skip to main content
اَخر الأخبار
Crypto faces historic $19 billion slide as Trump slaps 100% tariffs on Chinese tech
Markets poised for momentum shift as time cycles point to a key turning day on October 17: Harshubh Shah
Motilal Oswal recommends HDFC Bank, SBI as top picks ahead of RBI’s ECL regime transition
TCS, Tata Motors tumble up to 42% from peak, with over Rs 4L cr wiped off Tata stocks in 2025 amid boardroom turmoil
HCL Tech Q2 Results Preview: Revenue may rise up to 9.5% YoY; deal ramp-up to boost growth and margins
Gold and silver ETFs account for 72% of passive mutual fund inflows: AMFI
Tata Capital shares to get listed tomorrow. What to expect?
Market Trading Guide: Buy IDFC First Bank, PNB and 3 more stocks on Monday for up to 10% gains
Bandhan Aggressive Hybrid Fund’s winning playbook: Discipline, diversification, and long-term focus
الاحتلال يواصل اقتحام قرية برقة شمال غرب نابلس

AstraZeneca to become latest drugmaker to strike deal with Trump. Its stock is down but outperforming the market.

10 تشرين الأول 2025
AstraZeneca looks poised to announce a deal with U.S. President Donald Trump that’s focused on lowering drug prices, in a move that would see the British drugmaker follow in the footsteps of Pfizer.

For more details: Click here